Literature DB >> 28204730

The Effectiveness and Risks of Fluoroscopically Guided Lumbar Interlaminar Epidural Steroid Injections: A Systematic Review with Comprehensive Analysis of the Published Data.

Anil K Sharma1, Yakov Vorobeychik2, Ronald Wasserman3, Jessica Jameson4, Maxim Moradian5, Belinda Duszynski6, David J Kennedy7.   

Abstract

Objective: To determine the effectiveness and risks of fluoroscopically guided lumbar interlaminar epidural steroid injections. Design: Systematic review of the literature with comprehensive analysis of the published data. Interventions: Three reviewers with formal training in evidence-based medicine searched the literature on fluoroscopically guided lumbar interlaminar epidural steroid injections. A larger team consisting of five reviewers independently assessed the methodology of studies found and appraised the quality of the evidence presented. Outcome Measures: The primary outcome assessed was pain relief. Other outcomes such as functional improvement, reduction in surgery rate, decreased use of opioids/medications, and complications were noted, if reported. The evidence on each outcome was appraised in accordance with the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) system of evaluating evidence.
Results: The search yielded 71 primary publications addressing fluoroscopically guided lumbar interlaminar epidural steroid injections. There were no explanatory studies and all pragmatic studies identified were of low quality, yielding evidence comparable to observational studies. Conclusions: The body of evidence regarding effectiveness of fluoroscopically guided interlaminar epidural steroid injection is of low quality according to GRADE. Studies suggest a lack of effectiveness of fluoroscopically guided lumbar interlaminar epidural steroid injections in treating primarily axial pain regardless of etiology. Most studies on radicular pain due to lumbar disc herniation and stenosis do, however, report statistically significant short-term improvement in pain.

Entities:  

Keywords:  Image-Guided; Lumbar; Interlaminar; Steroid; Injection

Mesh:

Substances:

Year:  2017        PMID: 28204730     DOI: 10.1093/pm/pnw131

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  5 in total

1.  Long-term effectiveness of epidural steroid injections after new episodes of low back pain in older adults.

Authors:  Michele Curatolo; Sean D Rundell; Laura S Gold; P Suri; Janna L Friedly; Sdrj S Nedeljkovic; Richard A Deyo; Judith A Turner; Brian W Bresnahan; Andrew L Avins; Larry Kessler; Patrick J Heagerty; Jeffrey G Jarvik
Journal:  Eur J Pain       Date:  2022-05-29       Impact factor: 3.651

2.  A comparative study between interlaminar nerve root targeted epidural versus infraneural transforaminal epidural steroids for treatment of intervertebral disc herniation.

Authors:  Alaa-Eldin Adel El Maadawy; Alaa Mazy; Mohamed El Mitwalli Mansour El Adrosy; Ashraf Abdel-Moneim El-Mitwalli; Ayman Mohamed Abd El Naby; Mohammad Gomma
Journal:  Saudi J Anaesth       Date:  2018 Oct-Dec

3.  Recent Preoperative Lumbar Epidural Steroid Injection Is an Independent Risk Factor for Incidental Durotomy During Lumbar Discectomy.

Authors:  Lawal A Labaran; Varun Puvanesarajah; Sandesh S Rao; Dennis Chen; Francis H Shen; Amit Jain; Hamid Hassanzadeh
Journal:  Global Spine J       Date:  2019-03-21

4.  Comparative Clinical Effectiveness of Nonsurgical Treatment Methods in Patients With Lumbar Spinal Stenosis: A Randomized Clinical Trial.

Authors:  Michael J Schneider; Carlo Ammendolia; Donald R Murphy; Ronald M Glick; Elizabeth Hile; Dana L Tudorascu; Sally C Morton; Clair Smith; Charity G Patterson; Sara R Piva
Journal:  JAMA Netw Open       Date:  2019-01-04

5.  Effects of implementing evidence-based appropriateness guidelines for epidural steroid injection in chronic low back pain: the EAGER (Esi Appropriateness GuidElines pRotocol) study.

Authors:  Scott M Johnson; Troy Hutchins; Miriam Peckham; Yoshimi Anzai; Elizabeth Ryals; H Christian Davidson; Lubdha Shah
Journal:  BMJ Open Qual       Date:  2019-12-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.